Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nitin J Deshmukh

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Peptides|March 10, 2020
Glucagon-based therapy: Past, present and futureMohan Patil, Nitin J Deshmukh, Mahesh Patel, et al.
Drug Research|April 14, 2025
Therapeutic Potential of Sotagliflozin in Animal Models of Non-alcoholic Fatty Liver Disease with and without DiabetesNitin J Deshmukh, M S Kalshetti, Mohan Patil, et al.
Clinical and Experimental Pharmacology & Physiology|March 25, 2024
Exploring the modulatory effects of sotagliflozin on dyslipidemia in mice: The role of glucagon, fibroblast growth factor 21 and glucagon-like peptide 1Nitin J Deshmukh, M S Kalshetti, Mohan Patil, et al.
European Journal of Medicinal Chemistry|April 17, 2014
Synthesis and evaluation of cyclohexane carboxylic acid head group containing isoxazole and thiazole analogs as DGAT1 inhibitorsShivaji Kandre, Pundlik Rambhau Bhagat, M Mahesh Kumar Reddy, et al.
Antimicrobial Agents and Chemotherapy|March 11, 2020
Levonadifloxacin, a Novel Benzoquinolizine Fluoroquinolone, Modulates Lipopolysaccharide-Induced Inflammatory Responses in Human Whole-Blood Assay and Murine Acute Lung Injury ModelAnasuya Patel, Ganesh V Sangle, Jinal Trivedi, et al.
European Journal of Clinical Pharmacology|March 8, 2018
Evaluation of pharmacokinetic and pharmacodynamic parameters following single dose of sitagliptin in healthy Indian malesGanesh V Sangle, Mohan Patil, Nitin J Deshmukh, et al.
Inflammopharmacology|May 25, 2010
Oral bioavailability, efficacy and gastric tolerability of P2026, a novel nitric oxide-releasing diclofenac in ratAsif R Pathan, Manoj Karwa, Venu Pamidiboina, et al.
Metabolism: Clinical and Experimental|July 18, 2009
18F9 (4-(3,6-bis (ethoxycarbonyl)-4,5,6,7-tetrahydrothieno (2,3-c) pyridin-2-ylamino)-4-oxobutanoic acid) enhances insulin-mediated glucose uptake in vitro and exhibits antidiabetic activity in vivo in db/db miceRathinasabapathy Anandharajan, Sufyan G Sayyed, Lalit S Doshi, et al.
European Journal of Medicinal Chemistry|June 6, 2013
Evaluation of thiazole containing biaryl analogs as diacylglycerol acyltransferase 1 (DGAT1) inhibitorsKishorkumar S Kadam, Ravindra D Jadhav, Shivaji Kandre, et al.
Bioorganic & Medicinal Chemistry Letters|December 26, 2012
Lead optimization of isocytosine-derived xanthine oxidase inhibitorsKomal Bajaj, Sandeep Burudkar, Pranay Shah, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Peptides|March 10, 2020
Glucagon-based therapy: Past, present and futureMohan Patil, Nitin J Deshmukh, Mahesh Patel, et al.
Drug Research|April 14, 2025
Therapeutic Potential of Sotagliflozin in Animal Models of Non-alcoholic Fatty Liver Disease with and without DiabetesNitin J Deshmukh, M S Kalshetti, Mohan Patil, et al.
Clinical and Experimental Pharmacology & Physiology|March 25, 2024
Exploring the modulatory effects of sotagliflozin on dyslipidemia in mice: The role of glucagon, fibroblast growth factor 21 and glucagon-like peptide 1Nitin J Deshmukh, M S Kalshetti, Mohan Patil, et al.
European Journal of Medicinal Chemistry|April 17, 2014
Synthesis and evaluation of cyclohexane carboxylic acid head group containing isoxazole and thiazole analogs as DGAT1 inhibitorsShivaji Kandre, Pundlik Rambhau Bhagat, M Mahesh Kumar Reddy, et al.
Antimicrobial Agents and Chemotherapy|March 11, 2020
Levonadifloxacin, a Novel Benzoquinolizine Fluoroquinolone, Modulates Lipopolysaccharide-Induced Inflammatory Responses in Human Whole-Blood Assay and Murine Acute Lung Injury ModelAnasuya Patel, Ganesh V Sangle, Jinal Trivedi, et al.
European Journal of Clinical Pharmacology|March 8, 2018
Evaluation of pharmacokinetic and pharmacodynamic parameters following single dose of sitagliptin in healthy Indian malesGanesh V Sangle, Mohan Patil, Nitin J Deshmukh, et al.
Inflammopharmacology|May 25, 2010
Oral bioavailability, efficacy and gastric tolerability of P2026, a novel nitric oxide-releasing diclofenac in ratAsif R Pathan, Manoj Karwa, Venu Pamidiboina, et al.
Metabolism: Clinical and Experimental|July 18, 2009
18F9 (4-(3,6-bis (ethoxycarbonyl)-4,5,6,7-tetrahydrothieno (2,3-c) pyridin-2-ylamino)-4-oxobutanoic acid) enhances insulin-mediated glucose uptake in vitro and exhibits antidiabetic activity in vivo in db/db miceRathinasabapathy Anandharajan, Sufyan G Sayyed, Lalit S Doshi, et al.
European Journal of Medicinal Chemistry|June 6, 2013
Evaluation of thiazole containing biaryl analogs as diacylglycerol acyltransferase 1 (DGAT1) inhibitorsKishorkumar S Kadam, Ravindra D Jadhav, Shivaji Kandre, et al.
Bioorganic & Medicinal Chemistry Letters|December 26, 2012
Lead optimization of isocytosine-derived xanthine oxidase inhibitorsKomal Bajaj, Sandeep Burudkar, Pranay Shah, et al.
Pageof 2